Menu Expand
Unanswered Questions in Periodontology, An Issue of Dental Clinics of North America, E-Book

Unanswered Questions in Periodontology, An Issue of Dental Clinics of North America, E-Book

Frank A. Scannapieco

(2016)

Additional Information

Abstract

This issue, edited by Dr. Frank Scannapieco, is devoted to "Unanswered Questions in Periodontology." Review articles will help answer clinical questions such as: Can lost bone in furcations be regenerated?; What biomarkers exist to detect active periodontal disease?; Which mouthrinse products are beneficial for plaque control and gingival health?; Do mobility and occlusal trauma impact periodontal longevity?; Can peri-implantitis be treated?; Is there a genetic basis for periodontitis?; What is the minimal sample size for studies of periodontal treatment?; Does treatment of periodontal disease influence systemic disease?; Does periodontal disease cause cancer?; Is the use of photodynamic therapy beneficial to conventional mechanical therapy in the treatment of periodontitis and peri-implantitis?;  Are radiographs the best modality to diagnose and monitor periodontitis?; Does gingival recession require surgical treatment?; and Should antibiotics be prescribed to treat chronic periodontitis?

Table of Contents

Section Title Page Action Price
Front Cover Cover
Unanswered Questions\rin Periodontology i
Copyright ii
Contributors iii
EDITOR iii
AUTHORS iii
Contents vii
Preface: Unanswered Questions in Periodontology vii
What is the Contribution of Genetics to Periodontal Risk? vii
What is the Proper Sample Size for Studies of Periodontal Treatment? vii
Can Chemical Mouthwash Agents Achieve Plaque/Gingivitis Control? vii
Is Photodynamic Therapy an Effective Treatment for Periodontal and Peri-Implant Infections? viii
Is Radiologic Assessment of Alveolar Crest Height Useful to Monitor Periodontal Disease Activity? viii
Do Mobility and Occlusal Trauma Impact Periodontal Longevity? viii
Does Treatment of Periodontal Disease Influence Systemic Disease? viii
Should Antibiotics Be Prescribed to Treat Chronic Periodontitis? ix
Unanswered Questions: Can Bone Lost from Furcations Be Regenerated? ix
Can Periimplantitis Be Treated? ix
Does Gingival Recession Require Surgical Treatment? ix
DENTAL CLINICS OF NORTH AMERICA xi
FORTHCOMING ISSUES xi
January 2016 xi
April 2016 xi
July 2016 xi
RECENT ISSUES xi
July 2015 xi
April 2015 xi
January 2015 xi
Preface: Unanswered Questions in Periodontology xiii
What is the Contribution of Genetics to Periodontal Risk? 761
Key points 761
INTRODUCTION 761
PERIODONTITIS IS A COMPLEX DISEASE 762
PERIODONTITIS DEVELOPMENT AND PROGRESSION 764
SOME THEORETIC BACKGROUND ON GENETICS 766
HOW TO IDENTIFY PERIODONTITIS-ASSOCIATED GENETIC MARKERS 768
Candidate Gene Approach 768
The Genomewide Association Study Approach 770
THE BEST REPLICATED AND VALIDATED GENETIC FACTORS FOR PERIODONTITIS 771
COX2 on Chromosome 1 771
IL10 on Chromosome 1 771
IL1 Genes on Chromosome 2 772
DEFB1 on Chromosome 8 772
ANRIL on Chromosome 9 772
GLT6D1 on Chromosome 9 773
Other Suggested Periodontitis Genes Based on Genomewide Association Study 773
Other Suggested Periodontitis Genes Based on the Candidate Gene Approach 775
DISCUSSION AND CONCLUSIONS 775
REFERENCES 776
What is the Proper Sample Size for Studies of Periodontal Treatment? 781
Key points 781
INTRODUCTION 781
GENERAL REQUIREMENT OF SAMPLE SIZES FOR THE VALIDITY OF STATISTICAL TESTS 783
Tests for Categorical Data 783
Logistic Regression with Binary Outcomes 783
Tests for Numeric Data 784
Regression and Analysis of Variance with Numeric Outcomes 785
Goodness-of-Fit Testing 786
CHARACTERISTIC OF THE DATA IN PERIODONTAL RESEARCH AND THE CORRESPONDING SAMPLING DISTRIBUTIONS 786
CAUTION ON USING THE BOOTSTRAP METHOD FOR A SMALL SAMPLE SIZE 789
ALTERNATIVE METHODS FOR SMALL SAMPLE SIZES 790
Categorical Data Analysis 790
Exact Logistic Regression 791
Data Analysis with Numeric or Ordinal Data 791
Alternatives to Regression Given Small Sample Sizes 792
Confidence Intervals 793
DISCUSSION 794
REFERENCES 795
Can Chemical Mouthwash Agents Achieve Plaque/Gingivitis Control? 799
Key points 799
INTRODUCTION 800
MATERIALS AND METHODS 801
Focused Question 801
Search Strategy 801
Screening and Selection 801
Inclusion and Exclusion Criteria 802
Data Extraction and Assessment of Heterogeneity 802
Quality Assessment 802
Grading the ‘Body of Evidence’ 803
RESULTS 803
Search and Selection Results 803
Study Outcomes and Assessment of Heterogeneity 803
Quality Assessment 803
Active Ingredients 803
Single Active Ingredients 804
Alexidine 804
Cetylpyridinium chloride 816
Chlorhexidine 816
Delmopinol 817
Essential oils 817
Hexetidine 818
Oxygenating agents 818
Sanguinarine 818
Stannous fluoride 818
Triclosan 819
Comparisons of Active Ingredients 819
Chlorhexidine 0.12% versus chlorhexidine 0.2% 819
Essential oils versus chlorhexidine 819
Essential oil versus alcohol solution 819
Hexetidine versus chlorhexidine 820
Oxygenating agents versus chlorhexidine 820
Combination of Active Ingredients 820
Chlorhexidine and oxygenating agents 820
Evidence Profile 820
DISCUSSION 820
Grading 822
Side Effects 822
Chlorhexidine and sodium lauryl sulfate 823
Substantivity and bioavailability 823
Alcohol 824
Rinse Duration and Volume 824
Limitations of mouthwashes in the prevention of dental plaque formation 825
Cost-effectiveness 826
SUMMARY 826
ACKNOWLEDGMENTS 826
REFERENCES 826
Is Photodynamic Therapy an Effective Treatment for Periodontal and Peri-Implant Infections? 831
Key points 832
BIOLOGICAL RATIONALE 832
USE OF PHOTODYNAMIC THERAPY AS ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PATIENTS WITH UNTREATED CHRONIC PERIODONTITIS 833
USE OF PHOTODYNAMIC THERAPY AS ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PATIENTS WITH AGGRESSIVE PERIODONTITIS 844
USE OF PHOTODYNAMIC THERAPY AS AN ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN MAINTENANCE PERIODONTITIS PATIENTS 844
USE OF PHOTODYNAMIC THERAPY AS AN ALTERNATIVE TO SYSTEMIC OR LOCAL ANTIBIOTICS 844
SUMMARY 854
CLINICAL RECOMMENDATIONS 854
REFERENCES 855
Is Radiologic Assessment of Alveolar Crest Height Useful to Monitor Periodontal Disease Activity? 859
Key points 859
INTRODUCTION 859
RADIOGRAPHIC ASSESSMENT OF ALVEOLAR CREST LEVEL 860
RADIOGRAPHIC MEASUREMENT OF ALVEOLAR CREST HEIGHT 865
LOOKING TOWARD THE FUTURE OF RADIOGRAPHIC ASSESSMENT OF PERIODONTAL DISEASE 868
SUMMARY 870
ACKNOWLEDGMENTS 870
REFERENCES 870
Do Mobility and Occlusal Trauma Impact Periodontal Longevity? 873
Key points 873
HISTORICAL EVIDENCE 874
RECENT EVIDENCE: OCCLUSAL TRAUMA AND MOBILITY IMPACT ON PERIODONTITIS PROGRESSION 875
POTENTIAL INDICATIONS AND SCIENTIFIC RATIONALE FOR REDUCING OCCLUSAL TRAUMA IN PERIODONTITIS 876
IMPACT OF OCCLUSAL TRAUMA ON PERI-IMPLANT BONE LOSS 876
CLINICAL CONSIDERATIONS 877
ACKNOWLEDGMENTS 880
REFERENCES 880
Does Treatment of Periodontal Disease Influence Systemic Disease? 885
Key points 885
INTRODUCTION 885
Periodontitis—What Is It? 886
SYSTEMIC EFFECTS OF PERIODONTAL INFECTION 886
How Does Periodontal Infection Affect Systemic Health? 886
Bacteremia 887
The oral bacterial burden 888
Inflammation 888
What is inflammation? 888
Inflammation originating in the periodontal microbiome 889
Immune response 889
SYSTEMIC EFFECTS OF PERIODONTAL TREATMENT 889
Effects on Bacterial Load, Inflammation, and Immune Response 890
Effects of Periodontal Treatment on Local and Systemic Inflammation 890
Bacteremia 890
Inflammatory response 890
Immune response 891
A Special Note on Antibodies (Immune Response) to Periodontal Bacteria 891
Gingivitis Treatment Alone Also Has a Positive Effect on Bacterial Load and Inflammation 891
Effects on Systemic Diseases 892
Diabetes 892
Periodontitis: associations with diabetes and prediabetes 892
Periodontal infection: effects on blood glucose levels 892
How Inflammation Leads to Hyperglycemia—What to Tell the Patient 895
Periodontal Treatment in Type 2 Diabetes: Effects on Glycemic Control 895
The diabetes and periodontal therapy trial 896
Is a reduction of 0.4 percentage points HbA1c clinically meaningful? 898
Periodontal Treatment in Prediabetes: Effects on Blood Glucose Levels 898
Gingivitis Treatment Only: Effect on Inflammation in Diabetes 899
In summary 899
Metabolic Syndrome 899
Nonalcoholic Fatty Liver Disease 900
In summary 900
Cerebrocardiovascular Disease 900
Bacteremia 900
Inflammation 901
Periodontal treatment: effect on cardiovascular diseases and events 901
Periodontal treatment: effects on risk factors for cardiovascular events 901
Periodontal treatment: effect on intima media thickness and endothelial dysfunction 902
Rheumatoid Arthritis 902
Gingivitis treatment alone: effect on rheumatoid arthritis manifestation 903
In summary 903
Respiratory Tract Diseases 903
Aspiration pneumonia 903
Ventilator-assisted pneumonia 904
Chronic obstructive pulmonary disease 904
Chronic Kidney Disease 904
Periodontal treatment: effect on chronic kidney disease 904
In summary 904
Cancer 905
In summary 905
Other Diseases 905
Obesity 906
Pregnancy 906
Why It Is so Difficult to Determine Whether Periodontal Treatment Has Systemic Effects 906
SUMMARY 907
REFERENCES 908
Should Antibiotics Be Prescribed to Treat Chronic Periodontitis? 919
Key points 919
INTRODUCTION 919
PATIENT EVALUATION FOR POTENTIAL USE OF AN ANTIBIOTIC: OVERVIEW 922
EFFICACY OF SCALING AND ROOT PLANING AS THE SOLE TREATMENT OF PERIODONTITIS 923
EFFICACY OF SYSTEMIC ANTIBIOTICS AS THE SOLE TREATMENT OF PERIODONTITIS 923
EFFICACY OF SCALING AND ROOT PLANING COMBINED WITH SYSTEMIC ANTIBIOTICS 924
TREATMENT COMPLICATIONS AND RESISTANCE 925
EVALUATION OF OUTCOME AND LONG-TERM RECOMMENDATIONS 929
SUMMARY 929
REFERENCES 930
Unanswered Questions 935
Key points 935
INTRODUCTION 935
DIAGNOSIS AND CLASSIFICATION OF FURCATION DEFECTS 936
TREATMENT OF FURCATION DEFECTS 937
THE PROBLEM WITH PROBING 937
POUCHES WITHIN FURCATIONS 938
TYPES OF EVIDENCE FOR NEW BONE GROWTH IN FURCATION DEFECTS 938
HISTOLOGIC EVIDENCE FOR NEW BONE GROWTH IN FURCATION DEFECTS IN ANIMAL MODELS 940
HISTOLOGIC EVIDENCE FOR NEW BONE GROWTH IN HUMAN FURCATION DEFECTS 942
EVIDENCE FOR NEW BONE GROWTH IN HUMAN FURCATION DEFECTS OBTAINED BY SURGICAL REENTRY 944
PERIODONTAL REGENERATION 946
SUMMARY 947
REFERENCES 947
Can Periimplantitis Be Treated? 951
Key points 951
INTRODUCTION 951
Definition 952
Diagnosis 952
Classification 953
Epidemiology 954
Goals of Treatment 954
CONTROL OF CONTRIBUTING FACTORS 954
Patient-Related Factors 954
Smoking 954
Periodontal status 955
Implant-Related Factors 955
Implant position 955
Prosthetic considerations 958
THERAPEUTIC OPTIONS AND THEIR CLINICAL OUTCOMES 959
Nonsurgical Interventions 959
Antiinfective measures 959
Mechanical debridement 959
Chemotherapeutics 959
Lasers 961
Summary 961
Surgical Interventions 961
Access flap 967
Resective and regenerative 967
Summary 969
PROPOSED WORKFLOW 969
SUMMARY 971
REFERENCES 972
Does Gingival Recession Require Surgical Treatment? 981
Key points 982
INTRODUCTION 982
ETIOLOGY 983
Predisposing Factors 983
Precipitating Factors 984
PATHOGENESIS OF GINGIVAL RECESSION 986
FACTORS TO BE CONSIDERED FOR TREATING GINGIVAL RECESSION 987
Classification of Recession Defects 987
Patient’s Concerns 987
Unsatisfactory esthetics 989
Root hypersensitivity 989
Active Recession (Progression) 990
Restorative or Orthodontic Needs 990
TREATMENT GOALS 990
TREATMENT OUTCOMES OF VARIOUS SURGICAL PROCEDURES 991
SUMMARY AND FINAL REMARKS 992
REFERENCES 993
Index 997